1型糖尿病的干细胞衍生,完全分化的岛屿
Trevor W Reichman1, James F Markmann2, Jon Odorico3
1Toronto General Hospital, University Health Network, University of Toronto, Toronto.
The New England journal of medicine
|June 22, 2025
概括
新型干细胞疗法Zimislecel在恢复1型糖尿病患者的小岛功能方面表现有前途. 早期的结果表明改善了葡萄糖控制和胰岛素独立性,需要进一步研究.
科学领域:
- 再生医学是一种再生医学.
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 1型糖尿病 (T1D) 是一种自身免疫性疾病,其特征是破坏产生胰岛素的β细胞.
- 目前的管理依赖于外源性胰岛素,在实现最佳血糖控制和预防并发症方面存在局限性.
- 异性干细胞衍生小岛细胞疗法为恢复内源性胰岛素生产提供了一个潜在的替代方案.
研究的目的:
- 评估zimislecel在1型糖尿病患者中的安全性和有效性.
- 评估zimislecel在恢复生理小岛功能和改善血糖控制方面的潜力.
主要方法:
- 一个涉及1型糖尿病参与者的1-2期临床试验.
- 齐米斯莱塞尔 (半剂量或全剂量) 通过门静脉输液给药.
- 参与者接受了无葡萄糖皮质激素的免疫抑制疗法.
- 主要终点包括安全性,免于严重低血糖症和糖化血红蛋白水平.
- 二级终点包括胰岛素独立性和通过C-检测评估小岛功能.
主要成果:
- 所有参与者都显示了输液后植入和小岛功能的证据,可检测的C-水平表明了这一点.
- 全剂量组中的大多数参与者实现了严重低血糖的自由,并保持了糖化血红蛋白低于7%的水平.
- 全剂量组中的83%的参与者在第365天实现了胰岛素独立.
- 中性是最常见的严重不良事件;发生了两起死亡,与研究药物无关.
结论:
- 齐米斯莱塞尔在1型糖尿病患者中恢复生理小岛功能方面表现出潜力.
- 这些发现支持继续对齐米斯莱塞尔作为T1D治疗选择的临床研究.
- 需要进一步的研究来证实这些初步结果在更大,长期的研究中.
相关概念视频
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K
Induced Pluripotent Stem Cells
24.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.4K
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K


